Showing results (251-260 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|October 14, 2015
The chemotherapeutic drug boanmycin induces cell senescence and senescence-associated secretory phenotype factors, thus acquiring the potential to remodel the tumor microenvironmentPeng Chen, Hua Guo, Jinliang Chen, et al.
Anti-Cancer Drugs|October 16, 2015
The salicylanilide derivatives inhibit signal transducer and activator of transcription 3 pathways in A549 lung cancer cellsMinhua Hu, Wenfeng Ye, Jiaming Li, et al.
Anti-Cancer Drugs|October 16, 2015
Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydrationDaris Ferrari, Carla Codecà, Barbara Bocci, et al.
Anti-Cancer Drugs|October 20, 2015
Activity of nintedanib in germ cell tumorsGustav Steinemann, Christine Jacobsen, Mirjam Gerwing, et al.
Anti-Cancer Drugs|November 14, 2015
Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapyHui Chen, Ji Zhang, Guang Cao, et al.
Anti-Cancer Drugs|November 18, 2015
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastomaGaspar Reynés, Vicenta Martínez-Sales, Virtudes Vila, et al.
Anti-Cancer Drugs|November 18, 2015
Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case reportYoshikane Nonagase, Kunio Okamoto, Tsutomu Iwasa, et al.
Anti-Cancer Drugs|April 6, 2016
Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life reportJulien Langrand-Escure, Alexis Vallard, Romain Rivoirard, et al.
Anti-Cancer Drugs|February 27, 2016
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexesMark A Weinberg
Anti-Cancer Drugs|March 17, 2016
Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer: a preclinical studyLaura Lattanzio, Gerard Milano, Martino Monteverde, et al.
Pageof 464